CVSG
NEUTRALCVS Group Announces Director Dealings
The personal services company has announced changes to its major shareholdings.
CVS Group
1,244.00GBX
-0.48%
Market Cap
895.30M
Volume
136.26k
45% of avg
P/E Ratio
0.12
EPS (TTM)
99.9
Beta
1.06
Day Range
1,242.00p - 1,280.00p
52 Week Range
791.00p1,244.00p1,342.00p
1,244.00p
Upcoming Events
Late November 2025
Expected conclusion of CMA Market Investigation
High Impact Event
CVSG
NEUTRALCVS Group Responds to CMA Announcement on Veterinary Services
The veterinary services provider responds to the CMA's decision to extend its market investigation, noting it will continue to collaborate with the regulator.
CVSG
NEUTRALCVS Group Announces Director Share Purchase
The retailer has announced that its Chairman has purchased additional shares in the company.
CVSG
GOODCVS Group Completes Crematoria Disposal, Focuses on Veterinary Practices
The personal services company has completed the disposal of its crematoria operations, resulting in a one-off profit, while also expanding its veterinary practice business in Australia.
CVSG
NEUTRALCVS Group plc: Standard form for notification of major holdings
The personal services company has received a notification regarding a change in major shareholdings.
CVSG
GOODCVS Group Divests Crematorium Operations in £42.4m Deal
The veterinary services provider has agreed to sell its crematorium operations for £42.4 million, allowing the company to focus on its core business.
CVSG
NEUTRALCVS Group Announces Total Voting Rights
The veterinary services provider has announced its total issued share capital and voting rights as of the end of March 2025.
CVSG
NEUTRALCVS Group Announces PDMR Dealing
The veterinary services provider has disclosed a PDMR transaction involving the transfer of shares between accounts.
CVSG
NEUTRALCVS Group Announces Change in Major Shareholding
The retailer has announced a change in major shareholding, with Aberdeen Group plc increasing its stake to 6.88%.
CVSG
NEUTRALCVS Group Reports Mixed Interim Results with 6.6% Revenue Growth
The veterinary services provider reported 6.6% revenue growth to £341.8m in its interim results, despite challenging market conditions. Expansion in Australia offsets softer UK performance.